The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Recruiting now

Conditions studied: Hematologic Diseases

In brief

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Key facts

Study ID

NCT06222164

Run by

Invivoscribe, Inc.

People needed

2000

Starts

2024-03-30

Expected to finish

2027-06-30

Last updated by the study team

2025-05-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
• Donor Age ≥ 18 years

You may not qualify if…

• Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
• The specimens/samples have previously been enrolled in a clinical study

Where it is running

• LabPMM — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.